Differential distribution of the MeCP2 splice variants in the postnatal mouse brain
The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
Mutations in the gene encoding methyl CpG binding protein 2 (MeCP2) are the primary cause of the neurodevelopmental disorder Rett syndrome (RTT). Mecp2‐deficient mice develop a neurological phenotype that recapitulates many of the symptoms of RTT, including postnatal onset of the neurological deficits. MeCP2 has two isoforms, MeCP2e1 and MeCP2e2, with distinct amino termini, which are generated by alternative splicing. We examined the distribution of the Mecp2 splice variants in the postnatal mouse brain by in situ hybridization and found regional and age‐related differences in transcript abundance. In newborn mice, signals for total Mecp2 and the Mecp2e2 transcripts were widely distributed, with overlapping expression patterns throughout the brain. Expression of the Mecp2e2 splice variant became largely restricted to nuclei within the dorsal thalamus (DT) and cortical layer V in juvenile animals, a pattern that was maintained into adulthood. In contrast, the total Mecp2 riboprobe only weakly labeled the DT and cortical layer V in juvenile and adult animals, although it heavily labeled surrounding brain regions, suggesting that Mecp2e1 is the predominant transcript outside the thalamus. Quantitative real‐time PCR was used to measure Mecp2e1 and Mecp2e2 abundance in the diencephalon of adult mice, demonstrating significantly more Mecp2e2 in the DT than in the hypothalamus, which is in agreement with the Mecp2e2 in situ hybridization. The differential distribution of the Mecp2e1 and Mecp2e2 transcripts indicates regional and developmental regulation of Mecp2 splicing in the postnatal mouse brain. J. Comp. Neurol. 501:526–542, 2007. © 2007 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2
Amir, R. E., Van den Veyver, I. B., Wan, M., Tran, C. Q., Francke, U., & Zoghbi, H. Y. (1999) · Nature Genetics · doi:10.1038/13810 · Cited by 4,990 · cited 1×
“…X-linked methyl CpG binding protein 2 (MECP2) locus are considered the primary genetic cause underlying the neurological disorder Rett syndrome (RTT; Amir et al., 1999; for review see Caballero and Hendrich, 2005) and have also been reported in cases of nonspecific X-linked mental retardation…”
BackgroundA mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome
Guy, J., Hendrich, B., Holmes, M., Martin, J. E., & Bird, A. (2001) · Nature Genetics · doi:10.1038/85899 · Cited by 1,558
DNA Methylation-Related Chromatin Remodeling in Activity-Dependent Bdnf Gene Regulation
Martinowich, K., Hattori, D., Wu, H., Fouse, S., He, F., Hu, Y., Fan, G., & Sun, Y. E. (2003) · Science · doi:10.1126/science.1090842 · Cited by 1,405 · cited 1×
“…neurological disorder Rett syndrome (RTT; Amir et al., 1999; for review see Caballero and Hendrich, 2005) and have also been reported in cases of nonspecific X-linked mental retardation (Meloni et al., 2000; Orrico et al., 2000; Van Esch et al., 2005) and Angelman syndrome (Watson et al., 2001).”
BackgroundLewis, J. D., Meehan, R. R., Henzel, W. J., Maurer-Fogy, I., Jeppesen, P., Klein, F., & Bird, A. (1992) · Cell · doi:10.1016/0092-8674(92)90610-o · Cited by 1,371 · cited 1×
“In the central nervous system, alternative splicing has been shown to play an important role in such processes as axonal guidance, neuronal excitability, and synaptic efficacy (for review see Lipscombe, 2005).”
BackgroundDeficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice
Chen, R. Z., Akbarian, S., Tudor, M., & Jaenisch, R. (2001) · Nature Genetics · doi:10.1038/85906 · Cited by 1,275 · cited 19×
“In addition, MeCP2 protein levels were lowest in the thalamus and brainstem of patients with RTT (Armstrong et al., 2003).”
BackgroundInfluentialDerepression of BDNF Transcription Involves Calcium-Dependent Phosphorylation of MeCP2
Chen, W. G., Chang, Q., Lin, Y., Meissner, A., West, A. E., Griffith, E. C., Jaenisch, R., & Greenberg, M. E. (2003) · Science · doi:10.1126/science.1086446 · Cited by 1,232
On the actions that one nerve cell can have on another: distinguishing “drivers” from “modulators”
Sherman, S. M., & Guillery, R. W. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.12.7121 · Cited by 746 · cited 1×
“Cortical layer IV receives the majority of inputs arriving from the thalamus, whereas neurons in cortical layer V tend to send afferent projections to higher order thalamic nuclei (Sherman and Guillery, 1998).”
BackgroundDani, V. S., Chang, Q., Maffei, A., Turrigiano, G. G., Jaenisch, R., & Nelson, S. B. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506071102 · Cited by 639 · cited 2×
“In the Mecp2 knockout mice, the pyramidal cell neurons of layer V have abnormal dendritic structure and action potential firing rates (Armstrong et al., 1995; Dani et al., 2005).”
BackgroundKishi, N., & Macklis, J. D. (2004) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2004.07.006 · Cited by 445 · cited 22×
“…of Mecp2 mRNA within the mouse central nervous system that we observed is consistent with previous reports showing Mecp2 mRNA and protein throughout the mammalian brain (Shahbazian et al., 2002a; Jung et al., 2003; Kishi and Macklis, 2004; Mullaney et al., 2004; Braunschweig et al., 2004).”
BackgroundResultInfluentialClinical manifestations and stages of rett syndrome
Hagberg, B. (2002) · Mental Retardation and Developmental Disabilities Research Reviews · doi:10.1002/mrdd.10020 · Cited by 416
Cited by
The Story of Rett Syndrome: From Clinic to Neurobiology
Chahrour, M., & Zoghbi, H. Y. (2007) · Neuron · doi:10.1016/j.neuron.2007.10.001 · Cited by 1,265
“…abundant MeCP2-e1 isoform (encoded by MECP2 a ) contains 24 amino acids encoded by exon 1 and lacks the 9 amino acids encoded by exon 2, whereas the start site for the MeCP2-e2 isoform (encoded by MECP2 b ) is in exon 2 (Dragich et al., 2007; Kriaucionis and Bird, 2004; Mnatzakanian et al., 2004).”
Belichenko, P. V., Wright, E. E., Belichenko, N. P., Masliah, E., Li, H. H., Mobley, W. C., & Francke, U. (2009) · Journal of Comparative Neurology · doi:10.1002/cne.22009 · Cited by 272
An epigenetic framework for neurodevelopmental disorders: From pathogenesis to potential therapy
Millan, M. J. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.11.015 · Cited by 229
MECP2 disorders: from the clinic to mice and back
Lombardi, L. M., Baker, S. A., & Zoghbi, H. Y. (2015) · Journal of Clinical Investigation · doi:10.1172/jci78167 · Cited by 221
Dynamic protein–DNA recognition: beyond what can be seen
Fuxreiter, M., Simon, I., & Bondos, S. (2011) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2011.04.006 · Cited by 167
MECP2 Isoform-Specific Vectors with Regulated Expression for Rett Syndrome Gene Therapy
Rastegar, M., Hotta, A., Pasceri, P., Makarem, M., Cheung, A. Y. L., Elliott, S., Park, K. J., Adachi, M., Jones, F. S., Clarke, I. D., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006810 · Cited by 79
“higher expression of the E1 isoform in the brain [14], but no”
BackgroundWarita, K., Mitsuhashi, T., Ohta, K.-I., Suzuki, S., Hoshi, N., Miki, T., & Takeuchi, Y. (2013) · The Journal of Toxicological Sciences · doi:10.2131/jts.38.285 · Cited by 41
Metadata
- Authors
- Dragich, J. M., Kim, Y., Arnold, A. P., & Schanen, N. C.
- Venue
- Journal of Comparative Neurology
- Publisher
- Wiley
- Published
- 2007-02-02
- Volume
- 501
- Issue
- 4
- Pages
- 526-542
- ISSN
- 0021-9967 (ISSN-L)
- 1096-9861
- OpenAlex
- W2018771202
- Cited by
- 106
- References
- 14
- FWCI
- 2.68
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.